I have to agree with you Hawk. Bio is historically a long drawn out process & if people think Paul & Leslie are not progressing things on quick enough just consider what Yuman has said on multiple occasions. Surprised at how quickly testing is happening. Patience required for trials, SP and the quality management that runs Imugene. Easy to say management get too much remuneration but if the science holds up & the rewards comes into play, we will forget all about their remuneration & be thankful for their hard tedious work for fighting cancer.
IMU Price at posting:
5.3¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)